Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri and Reduced Bleeding on Probing (BOP)

Research synthesisModerate evidenceMixed effect size5 studies · 3 beneficial · 2 neutral · 0 harmful

Across 5 studies, 3 reported beneficial effects on reducing bleeding on probing (BOP) and 2 found no benefit over placebo. Effect sizes among beneficial studies ranged from small to large (mixed), with two RCTs showing moderate-to-large significant reductions and one observational study showing a small effect. The predominant population studied was adults with periodontitis (stages III/IV, grades B/C), including those with diabetes or betel quid chewing habits. Only 2 studies reported duration (median 101 days, about 14 weeks), but no consistent dose or form emerged across trials.

  • Studied populations: Patients with periodontitis (stages III/IV, grades B/C), including those with diabetes mellitus or betel quid chewing habits

Caveats: Two recent RCTs (2024, 2025) found no additional benefit of L. reuteri over placebo, while older RCTs (2015, 2019) and an observational study (2026) reported positive results. This temporal pattern suggests possible publication bias or diminishing effect over time. Sample sizes are small (20–30 per group in the RCTs), and the only beneficial RCT with large effect had a small sample (n=30). The 2026 observational study is low quality (evidence score 1). Overall, the evidence is inconsistent and the clinical significance remains uncertain.

Generated Jul 9, 2026
Doses used in studies
  • day: 2 (median 2, IQR 22) 1 study
  • lozenges/day: 2 (median 2, IQR 22) 1 study
Time to effect
Median: 3.4 months · IQR 8.7 weeks4.7 months · Range 3 weeks6 months — Reported in 2 of 5 studies
5 of 5 papers
Back to top